These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24113122)

  • 1. Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia.
    Chen S; Broqueres-You D; Yang G; Wang Z; Li Y; Wang N; Zhang X; Yang F; Tan Y
    Psychiatry Res; 2013 Dec; 210(3):825-9. PubMed ID: 24113122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis.
    Petruzzelli MG; Margari M; Peschechera A; de Giambattista C; De Giacomo A; Matera E; Margari F
    BMC Psychiatry; 2018 Aug; 18(1):246. PubMed ID: 30068291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male sex may be associated with higher metabolic risk in first-episode schizophrenia patients: A preliminary study.
    Chen S; Broqueres-You D; Yang G; Wang Z; Li Y; Yang F; Tan Y
    Asian J Psychiatr; 2016 Jun; 21():25-30. PubMed ID: 27208452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?
    Sengupta S; Parrilla-Escobar MA; Klink R; Fathalli F; Ying Kin Ng ; Stip E; Baptista T; Malla A; Joober R
    Schizophr Res; 2008 Jul; 102(1-3):329-36. PubMed ID: 18396386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameters of glucose and lipid metabolism at the fasted state in drug-naïve first-episode patients with psychosis: Evidence for insulin resistance.
    Petrikis P; Tigas S; Tzallas AT; Papadopoulos I; Skapinakis P; Mavreas V
    Psychiatry Res; 2015 Oct; 229(3):901-4. PubMed ID: 26279127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
    Jensen KG; Correll CU; Rudå D; Klauber DG; Stentebjerg-Olesen M; Fagerlund B; Jepsen JRM; Fink-Jensen A; Pagsberg AK
    J Clin Psychiatry; 2017; 78(8):e1035-e1046. PubMed ID: 28102978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose disturbances in first-episode drug-naïve schizophrenia: Relationship to psychopathology.
    Zhang XY; Chen DC; Tan YL; An HM; Zunta-Soares GB; Huang XF; Soares JC
    Psychoneuroendocrinology; 2015 Dec; 62():376-80. PubMed ID: 26385108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls.
    Wu X; Huang Z; Wu R; Zhong Z; Wei Q; Wang H; Diao F; Wang J; Zheng L; Zhao J; Zhang J
    Schizophr Res; 2013 Oct; 150(1):157-62. PubMed ID: 23998954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients.
    Arranz B; Rosel P; Ramírez N; Dueñas R; Fernández P; Sanchez JM; Navarro MA; San L
    J Clin Psychiatry; 2004 Oct; 65(10):1335-42. PubMed ID: 15491236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antipsychotic medications in glucose and lipid metabolism at the fasted state in drug-naïve first episode patients with psychosis after six months and three years of treatment.
    Petrikis P; Tigas S; Tzallas AT; Ntritsos G; Sioka C; Georgiou G; Karampas A; Skapinakis P; Mantas C; Hyphantis T
    Psychiatriki; 2024 Oct; 35(3):187-198. PubMed ID: 38814269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of glucose, insulin, and lipid disturbances in first-episode psychosis: a meta-analysis.
    Pillinger T; McCutcheon RA; Howes OD
    Psychol Med; 2023 May; 53(7):3150-3156. PubMed ID: 37449481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.
    Chen DC; Du XD; Yin GZ; Yang KB; Nie Y; Wang N; Li YL; Xiu MH; He SC; Yang FD; Cho RY; Kosten TR; Soares JC; Zhao JP; Zhang XY
    Psychol Med; 2016 Nov; 46(15):3219-3230. PubMed ID: 27604840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
    Henderson DC; Copeland PM; Borba CP; Daley TB; Nguyen DD; Cagliero E; Evins AE; Zhang H; Hayden DL; Freudenreich O; Cather C; Schoenfeld DA; Goff DC
    J Clin Psychiatry; 2006 May; 67(5):789-97. PubMed ID: 16841629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis.
    Nettis MA; Pergola G; Kolliakou A; O'Connor J; Bonaccorso S; David A; Gaughran F; Di Forti M; Murray RM; Marques TR; Blasi G; Bertolino A; Pariante CM; Dazzan P; Mondelli V
    Psychoneuroendocrinology; 2019 Jan; 99():145-153. PubMed ID: 30243054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
    Wu RR; Zhao JP; Liu ZN; Zhai JG; Guo XF; Guo WB; Tang JS
    Psychopharmacology (Berl); 2006 Jul; 186(4):572-8. PubMed ID: 16601995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps.
    Zhang B; Deng L; Wu H; Lu X; Peng L; Wu R; Guo W; Chen J; Li L; Zhao J
    Schizophr Res; 2016 Oct; 176(2-3):259-263. PubMed ID: 27377977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients.
    Dasgupta A; Singh OP; Rout JK; Saha T; Mandal S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1202-7. PubMed ID: 20600470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
    Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
    Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population.
    Perez-Iglesias R; Mata I; Pelayo-Teran JM; Amado JA; Garcia-Unzueta MT; Berja A; Martinez-Garcia O; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2009 Feb; 107(2-3):115-21. PubMed ID: 18993033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
    Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC
    Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.